{
  "type": "hyp",
  "text": "CsA treatment had no effect on IkappaB-alpha degradation IkappaB kinase (IKK) activity NF-kappaB binding activity and p65 nuclear import and export but reduced transcription of the NF-kappaB-dependent inducible nitric oxide synthase gene and a NF-kappaB-driven reporter gene.\n",
  "self": {
    "NER": {
      "answers": [
        "NF-kappaB",
        "NF-kappaB"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What does CsA have no effect on?",
          "What does CsA have no effect on?"
        ]
      }
    },
    "NOUN": {
      "answers": [
        "CsA treatment",
        "no effect",
        "IkappaB-alpha degradation IkappaB kinase (IKK) activity NF-kappaB binding activity",
        "p65 nuclear import",
        "export",
        "reduced transcription",
        "the NF-kappaB-dependent inducible nitric oxide synthase gene",
        "a NF-kappaB-driven reporter gene"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What treatment did not have an effect on IkappaB-alpha degradation?",
          "What effect did CsA have on IkappaB-alpha degradation?",
          "What did CsA treatment not have an effect on?",
          "What did CsA treatment not affect?",
          "What did CsA treatment not affect?",
          "What did CsA treatment do to the NF-kappaB-dependent in",
          "What did CsA treatment reduce transcription of?",
          "What did CsA treatment reduce transcription of?"
        ]
      }
    }
  },
  "asked": {
    "What is the mRNA that is reduced by treatment with CsA?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.21811771392822266,
        "ground_truth": {
          "TF": {
            "bertscore": 0.6967035531997681,
            "f1": 0
          }
        }
      }
    },
    "What transcription factor is known to contribute to the induction of the TF promotor in human": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.023056089878082275,
        "ground_truth": {
          "NF-kappaB": {
            "bertscore": 0.6519211530685425,
            "f1": 0
          }
        }
      }
    },
    "What is the method used to determine the effect of CsA on TF expression?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0078200101852417,
        "ground_truth": {
          "reverse transcription-polymerase chain reaction": {
            "bertscore": 0.5953657031059265,
            "f1": 0
          }
        }
      }
    },
    "What is another assay that shows that treatment with CsA leads to decreased TF": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.06807661056518555,
        "ground_truth": {
          "electrophoretic mobility shift": {
            "bertscore": 0.6725885272026062,
            "f1": 0
          }
        }
      }
    },
    "What leads to decreased TF mRNA expression?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.06255125999450684,
        "ground_truth": {
          "treatment": {
            "bertscore": 0.6978254318237305,
            "f1": 0
          }
        }
      }
    },
    "What drug is shown to decrease TF mRNA expression?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.09063524007797241,
        "ground_truth": {
          "CsA": {
            "bertscore": 0.7094430923461914,
            "f1": 0
          }
        }
      }
    },
    "What does treatment with CsA lead to decreased?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "transcription of the NF-kappaB-dependent inducible nitric",
        "answerability": 0.9751520752906799,
        "ground_truth": {
          "TF mRNA expression": {
            "bertscore": 0.7210409045219421,
            "f1": 0
          }
        }
      }
    },
    "What is the effect of treatment with CsA on NF-kappaB transcription": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "reduced transcription of the NF-kappaB-dependent inducible ni",
        "answerability": 0.7921662330627441,
        "ground_truth": {
          "reduced activation": {
            "bertscore": 0.698140561580658,
            "f1": 0.25
          }
        }
      }
    },
    "What transcription factor is reduced by treatment with CsA?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "NF-kappaB-dependent inducible nitric oxide syntha",
        "answerability": 0.9450410604476929,
        "ground_truth": {
          "the NF-kappaB transcription factor": {
            "bertscore": 0.7565026879310608,
            "f1": 0
          }
        }
      }
    },
    "What is the TF promotor known to contribute to?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.00041371583938598633,
        "ground_truth": {
          "the induction": {
            "bertscore": 0.6973357796669006,
            "f1": 0
          }
        }
      }
    },
    "What is the NF-kappaB transcription factor known to contribute to induction of": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.05831819772720337,
        "ground_truth": {
          "the TF promotor": {
            "bertscore": 0.6455512642860413,
            "f1": 0
          }
        }
      }
    },
    "What is known to contribute to the induction of the TF promotor?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0008275508880615234,
        "ground_truth": {
          "human monocytes": {
            "bertscore": 0.6539058685302734,
            "f1": 0
          }
        }
      }
    }
  }
}